City State Bank Halozyme Therapeutics, Inc. Transaction History
City State Bank
- $280 Million
- Q4 2024
A detailed history of City State Bank transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, City State Bank holds 110 shares of HALO stock, worth $6,281. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110
Previous 110
-0.0%
Holding current value
$6,281
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
536Shares Held
123MCall Options Held
294KPut Options Held
169K-
Black Rock Inc. New York, NY17.6MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$736 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$379 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$232 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$195 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.95B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...